Comparative analysis of sacubitril/valsartan and losartan potassium in the treatment of hypertension: efficacy, adverse reactions, and observations
CONCLUSION: For patients with hypertension, sacubitril/valsartan has a better treatment efficacy than losartan potassium, because it can effectively reduce blood pressure, the levels of inflammatory factors, and the rate of adverse reactions in patients.PMID:37854234 | PMC:PMC10579029
Source: American Journal of Translational Research - Category: Research Authors: Qunfei Ye Yanjun Sheng Xuan He Source Type: research
More News: Cozaar | Diovan | Hypertension | Liver | Losartan | Potassium | Research | Study | Urology & Nephrology